Literature DB >> 15886351

Response of the ubiquitin-proteasome pathway to changes in muscle activity.

Michael B Reid1.   

Abstract

The ubiquitin-proteasome pathway plays a critical role in the adaptation of skeletal muscle to persistent decreases or increases in muscle activity. This article outlines the basics of pathway function and reviews what we know about pathway responses to altered muscle use. The ubiquitin-proteasome pathway regulates proteolysis in mammalian cells by attaching ubiquitin polymers to damaged proteins; this targets the protein for degradation via the 26S proteasome. The pathway is constitutively active in muscle and continually regulates protein turnover. Conditions of decreased muscle use, e.g., unloading, denervation, or immobilization, stimulate general pathway activity. This activity increase is caused by upregulation of regulatory components in the pathway and leads to accelerated proteolysis, resulting in net loss of muscle protein. Pathway activity is also increased in response to exercise, a two-phase response. An immediate increase in selective ubiquitin conjugation by constitutive pathway components contributes to exercise-stimulated signal transduction. Over hours-to-days, exercise also stimulates a delayed increase in general ubiquitin conjugating activity by inducing expression of key components in the pathway. This increase mediates a late-phase rise in protein degradation that is required for muscle adaptation to exercise. Thus the ubiquitin-proteasome pathway functions as an essential mediator of muscle remodeling, both in atrophic states and exercise training.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  2005        PMID: 15886351     DOI: 10.1152/ajpregu.00545.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  45 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Inhibition of the ubiquitin-proteasome pathway does not protect against ventilator-induced accelerated proteolysis or atrophy in the diaphragm.

Authors:  Ashley J Smuder; W Bradley Nelson; Matthew B Hudson; Andreas N Kavazis; Scott K Powers
Journal:  Anesthesiology       Date:  2014-07       Impact factor: 7.892

Review 3.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

Review 4.  The molecular bases of training adaptation.

Authors:  Vernon G Coffey; John A Hawley
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  Proteolysis activation and proteome alterations in murine skeletal muscle submitted to 1 week of hindlimb suspension.

Authors:  Rita Ferreira; Rui Vitorino; Maria João Neuparth; Hans-Joachim Appell; José Alberto Duarte; Francisco Amado
Journal:  Eur J Appl Physiol       Date:  2009-08-19       Impact factor: 3.078

Review 6.  The exercise-induced stress response of skeletal muscle, with specific emphasis on humans.

Authors:  James P Morton; Anna C Kayani; Anne McArdle; Barry Drust
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

7.  Post-exercise cold water immersion does not alter high intensity interval training-induced exercise performance and Hsp72 responses, but enhances mitochondrial markers.

Authors:  Paula Fernandes Aguiar; Sílvia Mourão Magalhães; Ivana Alice Teixeira Fonseca; Vanessa Batista da Costa Santos; Mariana Aguiar de Matos; Marco Fabrício Dias Peixoto; Fábio Yuzo Nakamura; Craig Crandall; Hygor Nunes Araújo; Leonardo Reis Silveira; Etel Rocha-Vieira; Flávio de Castro Magalhães; Fabiano Trigueiro Amorim
Journal:  Cell Stress Chaperones       Date:  2016-06-08       Impact factor: 3.667

Review 8.  Bench-to-bedside review: mobilizing patients in the intensive care unit--from pathophysiology to clinical trials.

Authors:  Alex D Truong; Eddy Fan; Roy G Brower; Dale M Needham
Journal:  Crit Care       Date:  2009-07-13       Impact factor: 9.097

Review 9.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.